Neoadjuvant dabrafenib and trametinib for functional organ preservation in recurrent BRAF V600E-mutated papillary thyroid cancerJanice L. Farlow, Amit Agrawal, Bhavana Konda et al.|Oral Oncology|2023Cited by 11
Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutationsDorota Whitmer, Joyce Shin, John E. Phay et al.|Frontiers in Endocrinology|2022Cited by 7